July 24, 2017 / 12:18 PM / 3 months ago

BRIEF-Essa Pharma provides further update on proposed equity offering

July 24 (Reuters) - Essa Pharma Inc-

* Essa Pharma provides further update on proposed equity offering

* Essa Pharma says had received sufficient investor interest to advance proposed transaction but was denied conditional approval by financial regulators

* Essa Pharma Inc says denied approval due to levels of insider and institutional participation for the proposed equity offering

* Essa Pharma - intends to delay an offering until after data can be announced from ongoing highest dose cohorts phase 1 clinical trial of EPI-506 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below